tiprankstipranks
Scinai Immunotherapeutics Ltd. Sponsored Adr (SCNI)
:SCNI
US Market

Scinai Immunotherapeutics (SCNI) Income Statement

Compare
307 Followers

Scinai Immunotherapeutics Income Statement

Last quarter (Q3 2024), Scinai Immunotherapeutics's total revenue was $168.00K, an increase of Infinity% from the same quarter last year. In Q3, Scinai Immunotherapeutics's net income was $10.46M. See Scinai Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 9.71M$ 11.06M$ 10.87M$ -2.28M$ 22.69M
Depreciation and Amortization
$ 514.00K$ 562.00K$ 471.00K$ 468.56K$ 461.69K
EBITDA
$ -9.19M$ -10.50M$ -10.39M$ 2.75M$ -22.21M
Operating Income
$ -9.71M$ -11.06M$ -10.87M$ 2.28M$ -22.69M
Other Income/Expenses
$ 3.21M$ 5.26M$ 2.67M$ -3.67M$ -8.93M
Pretax Income
$ -6.50M$ -5.80M$ -8.21M$ -1.39M$ -31.62M
Net Income
$ -6.50M$ -5.80M$ -8.21M$ -1.39M$ -31.62M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -16.64$ -30.74$ -58.14$ -12.51$ -387.21
Diluted EPS
$ -16.64$ -30.74$ -58.14$ -12.51$ -387.21
Weighted Average Shares Outstanding
390.66K 188.52K 141.14K 110.81K 81.66K
Weighted Average Shares Outstanding (Diluted)
390.66K 188.52K 141.14K 110.81K 81.66K
Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis